Resilient T cell responses to B.1.1.529 (Omicron) SARS-CoV-2 variant
Mladen Jergovic, Christopher P. Coplen, Jennifer L. Uhrlaub, Shawn C. Beitel, Jefferey L. Burgess, Karen Lutrick, Katherine D. Ellingson, Makiko Watanabe, Janko Nikolich-Žugich
doi: https://doi.org/10.1101/2022.01.16.22269361
Mladen Jergovic
1Department of Immunobiology, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA
2University of Arizona Center on Aging, University of Arizona, College of Medicine-Tucson, Tucson, AZ, USA
Christopher P. Coplen
1Department of Immunobiology, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA
2University of Arizona Center on Aging, University of Arizona, College of Medicine-Tucson, Tucson, AZ, USA
Jennifer L. Uhrlaub
1Department of Immunobiology, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA
2University of Arizona Center on Aging, University of Arizona, College of Medicine-Tucson, Tucson, AZ, USA
Shawn C. Beitel
3Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA
Jefferey L. Burgess
3Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA
4BIO5 Institute, University of Arizona, Tucson, USA
Karen Lutrick
5Department of Family and Community Medicine, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA
Katherine D. Ellingson
3Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA
Makiko Watanabe
1Department of Immunobiology, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA
2University of Arizona Center on Aging, University of Arizona, College of Medicine-Tucson, Tucson, AZ, USA
Janko Nikolich-Žugich
1Department of Immunobiology, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA
2University of Arizona Center on Aging, University of Arizona, College of Medicine-Tucson, Tucson, AZ, USA
4BIO5 Institute, University of Arizona, Tucson, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present work are contained in the manuscript.
Posted January 16, 2022.
Resilient T cell responses to B.1.1.529 (Omicron) SARS-CoV-2 variant
Mladen Jergovic, Christopher P. Coplen, Jennifer L. Uhrlaub, Shawn C. Beitel, Jefferey L. Burgess, Karen Lutrick, Katherine D. Ellingson, Makiko Watanabe, Janko Nikolich-Žugich
medRxiv 2022.01.16.22269361; doi: https://doi.org/10.1101/2022.01.16.22269361
Resilient T cell responses to B.1.1.529 (Omicron) SARS-CoV-2 variant
Mladen Jergovic, Christopher P. Coplen, Jennifer L. Uhrlaub, Shawn C. Beitel, Jefferey L. Burgess, Karen Lutrick, Katherine D. Ellingson, Makiko Watanabe, Janko Nikolich-Žugich
medRxiv 2022.01.16.22269361; doi: https://doi.org/10.1101/2022.01.16.22269361
Subject Area
Subject Areas
- Addiction Medicine (329)
- Allergy and Immunology (648)
- Anesthesia (173)
- Cardiovascular Medicine (2484)
- Dermatology (209)
- Emergency Medicine (384)
- Epidemiology (11947)
- Forensic Medicine (10)
- Gastroenterology (714)
- Genetic and Genomic Medicine (3874)
- Geriatric Medicine (358)
- Health Economics (648)
- Health Informatics (2503)
- Health Policy (963)
- Hematology (350)
- HIV/AIDS (812)
- Medical Education (384)
- Medical Ethics (106)
- Nephrology (411)
- Neurology (3638)
- Nursing (204)
- Nutrition (542)
- Oncology (1887)
- Ophthalmology (549)
- Orthopedics (229)
- Otolaryngology (298)
- Pain Medicine (240)
- Palliative Medicine (71)
- Pathology (459)
- Pediatrics (1066)
- Primary Care Research (434)
- Public and Global Health (6305)
- Radiology and Imaging (1335)
- Respiratory Medicine (845)
- Rheumatology (388)
- Sports Medicine (333)
- Surgery (424)
- Toxicology (51)
- Transplantation (179)
- Urology (152)